MedXY News
EnglishTagprostate cancer
43 all articles · 20 / page
Ask MedXY AI
Latest news
Tag
EN
PARP inhibitors shine: How the TALAPRO-2 trial is changing the landscape of prostate cancer with precision medicine
Treatment for advanced prostate cancer has advanced significantly in the past decade, but metastatic castration-resistant...
Section: Clinical UpdatesOct 2, 2025
EN
Early Toxicity Comparison of Moderately Hypofractionated Radiotherapy and Stereotactic Body Radiotherapy in Prostate Cancer: Insights from the PACE-C Trial
The PACE-C phase 3 trial shows that stereotactic body radiotherapy (SBRT) and moderately hypofractionated radiotherapy (MHRT) have comparable early toxicity profiles in intermediate- and high-risk prostate cancer patients.
